Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease

Journal of Neuroimmunology

Volumn 274, Issue 1-2, 2014, Pages 78-85

  Takizawa, Sho ^a   Kaneyama, Tomoki ^a   Tsugane, Sayaka ^a   Takeichi, Naoya ^a   Yanagisawa, Satoshi ^a   Ichikawa, Motoki ^a   Yagita, Hideo ^b   Kim, Byung S ^c   Koh, Chang Sung ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Demyelination; Multiple sclerosis (MS); PD L1; Programmed Death 1 (PD 1); Theiler's murine encephalomyelitis virus induced demyelinating disease (TMEV IDD)

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; IN VIVO STUDY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SPINAL CORD; THEILER MURINE ENCEPHALOMYELITIS VIRUS INDUCED DEMYELINATING DISEASE; UPREGULATION;

DEMYELINATION; MULTIPLE SCLEROSIS (MS); PD-L1; PROGRAMMED DEATH-1 (PD-1); THEILER'S MURINE ENCEPHALOMYELITIS VIRUS-INDUCED DEMYELINATING DISEASE (TMEV-IDD);

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD274; CELL LINE; CRICETINAE; DEMYELINATING DISEASES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; INTERFERON-GAMMA; KIDNEY; MICE; MICE, INBRED STRAINS; PROGRAMMED CELL DEATH 1 RECEPTOR; SPINAL CORD; TH1 CELLS; THEILOVIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906935767     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.06.018     Document Type: Article

References (56)

1. Allen I., Brankin B. Pathogenesis of multiple sclerosis-the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 1993, 52:95-105.
2. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 2003, 198:63-69.
3. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001, 167:1245-1253.
4. Brahic M., Stroop W.G., Baringer J.R. Theiler's virus persists in glial cells during demyelinating disease. Cell 1981, 26:123-128.
5. Brown J.A., Dorfman D.M., Ma F.R., Sullivan E.L., Munoz O., Wood C.R., et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003, 170:1257-1266.
6. Carter L.L., Leach M.W., Azoitei M.L., Cui J., Pelker J.W., Jussif J., et al. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 182:124-134.
7. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 1986, 136:920-927.
8. Clatch R.J., Miller S.D., Metzner R., Dal Canto M.C., Lipton H.L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 1990, 176:244-254.
9. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Investig. 1975, 33:626-637.
10. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192:1027-1034.
11. Friedmann A., Frankel G., Lorch Y., Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 1987, 61:898-903.
12. Gerety S.J., Rundell M.K., Dal Canto M.C., Miller S.D. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J Immunol 1994, 152:919-929.
13. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 2005, 23:515-548.
14. Hou W., Kang H.S., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med. 2009, 206:313-328.
15. Ishida M., Iwai Y., Tanaka Y., Okazaki T., Freeman G.J., Minato N., et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett. 2002, 84:57-62.
16. Jin Y.H., Kang B., Kim B.S. Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice. J. Virol. 2009, 83:10981-10992.
17. Kappel C.A., Dal Canto M.C., Melvold R.W., Kim B.S. Hierarchy of effects of the MHC and T cell receptor beta-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 1991, 147:4322-4326.
18. Karpus W.J., Pope J.G., Peterson J.D., Dal Canto M.C., Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 1995, 155:947-957.
19. Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008, 26:677-704.
20. Kim B.S., Yauch R.L., Bahk Y.Y., Kang J.A., Dal Canto M.C., Hall C.K. A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J. Virol. 1998, 72:1020-1027.
21. Kurtzke J.F., Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology 1986, 36:307-328.
22. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-268.
23. Lehrich J.R., Arnason B.G., Hochberg F.H. Demyelinative myelopathy in mice induced by the DA virus. J. Neurol. Sci. 1976, 29:149-160.
24. Lipton H.L., Dal Canto M.C. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 1976, 30:201-207.
25. Lipton H.L., Kratochvil J., Sethi P., Dal Canto M.C. Theiler's virus antigen detected in mouse spinal cord 2 1/2years after infection. Neurology 1984, 34:1117-1119.
26. Lipton H.L., Calenoff M., Bandyopadhyay P., Miller S.D., Dal Canto M.C., Gerety S., et al. The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J. Virol. 1991, 65:4370-4377.
27. Lipton H.L., Twaddle G., Jelachich M.L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 1995, 69:2525-2533.
28. Lohmann T., Leslie R.D., Londei M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 1996, 9:385-389.
29. Loke P., Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5336-5341.
30. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Neville K.L., Yauch R.L., et al. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J. Neurovirol. 1997, 3(Suppl. 1):S62-S65.
31. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
32. Myoung J., Bahk Y.Y., Kang H.S., Dal Canto M.C., Kim B.S. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. J. Virol. 2008, 82:5606-5617.
33. Nathanson N., Miller A. Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. Am. J. Epidemiol. 1978, 107:451-461.
34. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
35. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291:319-322.
36. Nurieva R.I., Liu X., Dong C. Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol. Rev. 2009, 229:88-100.
37. Okazaki T., Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 2007, 19:813-824.
38. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
39. Peterson J.D., Karpus W.J., Clatch R.J., Miller S.D. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 1993, 23:46-55.
40. Pevear D.C., Calenoff M., Rozhon E., Lipton H.L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J. Virol. 1987, 61:1507-1516.
41. Rodriguez M., Lafuse W.P., Leibowitz J., David C.S. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 1986, 36:964-970.
42. Salama A.D., Chitnis T., Imitola J., Ansari M.J., Akiba H., Tushima F., et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2003, 198:71-78.
43. Sandner S.E., Clarkson M.R., Salama A.D., Sanchez-Fueyo A., Domenig C., Habicht A., et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 2005, 174:3408-3415.
44. Sharpe A.H. Mechanisms of costimulation. Immunol. Rev. 2009, 229:5-11.
45. Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007, 8:239-245.
46. Takeichi N., Yanagisawa S., Kaneyama T., Yagita H., Jin Y.H., Kim B.S., et al. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int. Immunol. 2010, 22:729-738.
47. Tsugane S., Takizawa S., Kaneyama T., Ichikawa M., Yagita H., Kim B.S., et al. Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neuroimmunol. 2012, 252:66-74.
48. van Noort J.M., van Sechel A., Boon J., Boersma W.J., Polman C.H., Lucas C.J. Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjects. J. Neuroimmunol. 1993, 46:67-72.
49. Wang J., Yoshida T., Nakaki F., Hiai H., Okazaki T., Honjo T. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11823-11828.
50. Wekerle H. Immunopathogenesis of multiple sclerosis. Acta Neurol. (Napoli) 1991, 13:197-204.
51. Welsh C.J., Tonks P., Nash A.A., Blakemore W.F. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 1987, 68(Pt 6):1659-1667.
52. Williams I.R., Unanue E.R. Costimulatory requirements of murine Th1 clones. The role of accessory cell-derived signals in responses to anti-CD3 antibody. J. Immunol. 1990, 145:85-93.
53. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., et al. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002, 169:5538-5545.
54. Yamazaki T., Akiba H., Koyanagi A., Azuma M., Yagita H., Okumura K. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J. Immunol. 2005, 175:1586-1592.
55. Yanagisawa S., Takeichi N., Kaneyama T., Yagita H., Taniguchi S., Kim B.S., et al. Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Brain Res. 2010, 1317:236-245.
56. Yauch R.L., Palma J.P., Yahikozawa H., Koh C.S., Kim B.S. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 1998, 72:6169-6174.